⟵ Back to Search Results

BGB-3111-205

Completed

Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Beigene Study ID info

BGB-3111-205

ClinicalTrials.gov ID info

NCT03206918

China Drug Trials ID info

CTR20160890

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan